Tatchaporn Ongphichetmetha

Rama IV Road
Bangkok, 10330, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Multimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.

Multimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.

Journal: Multiple sclerosis and related disorders
Published: July 04, 2026

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 23, 2026

Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.

Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.

Journal: Multiple sclerosis and related disorders
Published: April 24, 2026

Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Journal: Journal of clinical medicine research
Published: February 07, 2026

FDG-PET Associations With Disease Severity and Outcomes in NMDA-Receptor IgG Autoimmune Encephalitis.

FDG-PET Associations With Disease Severity and Outcomes in NMDA-Receptor IgG Autoimmune Encephalitis.

Journal: Annals of clinical and translational neurology
Published: December 01, 2025

The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis.

The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis.

Journal: Scientific reports
Published: September 17, 2025

Frequency of Seroconversion in Aquaporin-4 Antibody Testing: Insights From Real-World Data.

Frequency of Seroconversion in Aquaporin-4 Antibody Testing: Insights From Real-World Data.

Journal: Annals of clinical and translational neurology
Published: April 22, 2025

Real-world data and patient perspectives on the impact of multiple sclerosis, neuromyelitis optica spectrum disorder, and related disorders on employment.

Real-world data and patient perspectives on the impact of multiple sclerosis, neuromyelitis optica spectrum disorder, and related disorders on employment.

Journal: Multiple sclerosis and related disorders
Published: April 02, 2025

Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis.

Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis.

Journal: Annals of clinical and translational neurology
Published: March 05, 2025

Reference range for serum neurofilament light chain: findings from healthy Thai adults.

Reference range for serum neurofilament light chain: findings from healthy Thai adults.

Journal: Brain communications
Published: January 13, 2025

Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.

Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.

Journal: Annals of neurology
Published: December 06, 2024

Cognitive performance in patients with neuromyelitis optica: clinical and imaging characteristics.

Cognitive performance in patients with neuromyelitis optica: clinical and imaging characteristics.

Journal: Scientific reports
Published: May 30, 2024
Showing 1-12 of 23

Last Updated: 09/26/2026